Form D · Other
Capstone Therapeutics Corp.
Tempe, AZ · CIK 0000887151
Offering snapshot reported Jul 17, 2017 · SEC filing
- Reported sold
- $0 Offering amount: $3.44M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 14, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 17, 2017 | Initial | $0 | No comparison | 0 | SEC filing |
| Mar 15, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 15, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-290921
Source: Form D, filed Jul 17, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Holliman, Iii | Executive |
| Les Taeger | Executive |
| Leslie Taeger | Executive |
Issuer details
Industry: Other (See others in industry)
Address:
1275 West Washington Street Suite 104
Tempe, AZ, 85281
Tempe, AZ, 85281